Alimera Sciences Inc
NASDAQ:ALIM

Watchlist Manager
Alimera Sciences Inc Logo
Alimera Sciences Inc
NASDAQ:ALIM
Watchlist
Price: 5.54 USD -0.18% Market Closed
Market Cap: 301.3m USD

Net Margin
Alimera Sciences Inc

-15.3%
Current
-22%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-15.3%
=
Net Income
-15.3m
/
Revenue
99.7m

Net Margin Across Competitors

No Stocks Found

Alimera Sciences Inc
Glance View

Market Cap
290.2m USD
Industry
Pharmaceuticals

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. The company is headquartered in Alpharetta, Georgia and currently employs 145 full-time employees. The company went IPO on 2010-04-22. The firm is engaged in commercialization and development of prescription ophthalmic pharmaceuticals. The firm focuses on diseases affecting the retina. The Company’s commercial product, ILUVIEN, is an intravitreal implant that treats patients by delivering a continuous microdose of the corticosteroid fluocinolone acetonide (FAc) in the eye, for up to 36 months. The Company’s product ILUVIEN is also used for the treatment of diabetic macular edema (DME). DME is a disease of retina that affects individuals with diabetes and can lead to severe vision loss and blindness. Its ILUVIEN is also used in the European Economic Area (EEA) to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). The firm commercially market ILUVIEN directly in the United States, Germany, United Kingdom, Portugal, and Ireland.

ALIM Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-15.3%
=
Net Income
-15.3m
/
Revenue
99.7m
What is the Net Margin of Alimera Sciences Inc?

Based on Alimera Sciences Inc's most recent financial statements, the company has Net Margin of -15.3%.

Back to Top